Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy
Conditions: Breast Neoplasms Interventions: Drug: Carrellizumab + Capecitabine; Drug: Placebo + Capecitabine Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Study | Xeloda